;PMID: 2861116
;source_file_1803.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..37] = [t:0..37]
;1)sentence:[e:43..96] = [t:43..96]
;2)section:[e:100..155] = [t:100..155]
;3)sentence:[e:159..471] = [t:159..471]
;4)sentence:[e:473..748] = [t:473..748]
;5)sentence:[e:749..999] = [t:749..999]
;6)sentence:[e:1000..1161] = [t:1000..1161]
;7)sentence:[e:1162..1394] = [t:1162..1394]
;8)section:[e:1398..1442] = [t:1398..1442]

;section 0 Span:0..37
;Fertil Steril. 1985 Jul;44(1):125-32.
(SEC
  (FRAG (NNP:[0..6] Fertil) (NNP:[7..13] Steril) (.:[13..14] .)
        (CD:[15..19] 1985) (::[20..27] Jul;44-LRB-) (CD:[27..28] 1)
        (-RRB-:[28..29] -RRB-) (::[29..30] :) (CD:[30..36] 125-32)
        (.:[36..37] .)))

;sentence 1 Span:43..96
;Impaired testosterone biosynthesis in cryptorchidism.
;[52..64]:substance:"testosterone"
(SENT
  (NP-HLN
    (NP (VBN:[43..51] Impaired) (NN:[52..64] testosterone)
        (NN:[65..77] biosynthesis))
    (PP-LOC (IN:[78..80] in)
      (NP (NN:[81..95] cryptorchidism)))
    (.:[95..96] .)))

;section 2 Span:100..155
;Farrer JH, Sikka SC, Xie HW, Constantinide D, Rajfer J.
(SEC
  (FRAG (NNP:[100..106] Farrer) (NNP:[107..109] JH) (,:[109..110] ,)
        (NNP:[111..116] Sikka) (NNP:[117..119] SC) (,:[119..120] ,)
        (NNP:[121..124] Xie) (NNP:[125..127] HW) (,:[127..128] ,)
        (NNP:[129..142] Constantinide) (NNP:[143..144] D) (,:[144..145] ,)
        (NNP:[146..152] Rajfer) (NNP:[153..155] J.)))

;sentence 3 Span:159..471
;In an attempt to determine whether the production and synthesis of
;testosterone  (T) by the testis is impaired by the cryptorchid state, the
;ability of the  cryptorchid rat testis to form T was assessed at various time
;periods into  adulthood after the surgical induction of cryptorchidism in the
;newborn period.
;[226..238]:substance:"testosterone"
;[241..242]:substance:"T"
;[347..348]:substance:"T"
(SENT
  (S
    (PP (IN:[159..161] In)
      (NP (DT:[162..164] an) (NN:[165..172] attempt)
        (S
          (NP-SBJ (-NONE-:[172..172] *))
          (VP (TO:[173..175] to)
            (VP (VB:[176..185] determine)
              (SBAR (IN:[186..193] whether)
                (S
                  (NP-SBJ-2
                    (NP (DT:[194..197] the) (NN:[198..208] production)
                        (CC:[209..212] and) (NN:[213..222] synthesis))
                    (PP (IN:[223..225] of)
                      (NP
                        (NP (NN:[226..238] testosterone))
                        (NP (-LRB-:[240..241] -LRB-) (NN:[241..242] T)
                            (-RRB-:[242..243] -RRB-))))
                    (PP (IN:[244..246] by)
                      (NP (DT:[247..250] the) (NN:[251..257] testis))))
                  (VP (VBZ:[258..260] is)
                    (VP (VBN:[261..269] impaired)
                      (NP-2 (-NONE-:[269..269] *))
                      (PP (IN:[270..272] by)
                        (NP-LGS (DT:[273..276] the) (NN:[277..288] cryptorchid)
                                (NN:[289..294] state))))))))))))
    (,:[294..295] ,)
    (NP-SBJ-1
      (NP (DT:[296..299] the) (NN:[300..307] ability)
        (S-4 (-NONE-:[307..307] *ICH*)))
      (PP (IN:[308..310] of)
        (NP (DT:[311..314] the) (NN:[316..327] cryptorchid) (NN:[328..331] rat)
            (NN:[332..338] testis)))
      (S-4
        (NP-SBJ (-NONE-:[338..338] *))
        (VP (TO:[339..341] to)
          (VP (VB:[342..346] form)
            (NP (NN:[347..348] T))))))
    (VP (VBD:[349..352] was)
      (VP (VBN:[353..361] assessed)
        (NP-1 (-NONE-:[361..361] *))
        (PP-TMP (IN:[362..364] at)
          (NP
            (NP (JJ:[365..372] various) (NN:[373..377] time)
                (NNS:[378..385] periods))
            (PP (IN:[386..390] into)
              (NP (NN:[392..401] adulthood)))))
        (PP (IN:[402..407] after)
          (NP
            (NP
              (NP (DT:[408..411] the) (JJ:[412..420] surgical)
                  (NN:[421..430] induction))
              (PP (IN:[431..433] of)
                (NP (NN:[434..448] cryptorchidism))))
            (PP-TMP (IN:[449..451] in)
              (NP (DT:[452..455] the) (JJ:[456..463] newborn)
                  (NN:[464..470] period)))))))
    (.:[470..471] .)))

;sentence 4 Span:473..748
;The intratesticular T content of the descended testis rose from 0.3 ng/testis
;at  14 days of age to 71.2 ng/testis at adulthood (day 56); whereas in the 
;cryptorchid testis, the values were 0.4 ng/testis and 2.0 ng/testis, 
;respectively, at the same ages (P less than 0.001).
;[493..494]:substance:"T"
;[537..540]:quantitative-value:"0.3"
;[541..550]:quantitative-units:"ng/testis"
;[555..557]:quantitative-value:"14"
;[558..562]:quantitative-units:"days"
;[573..577]:quantitative-value:"71.2"
;[578..587]:quantitative-units:"ng/testis"
;[602..605]:quantitative-units:"day"
;[606..608]:quantitative-value:"56"
;[663..666]:quantitative-value:"0.4"
;[667..676]:quantitative-units:"ng/testis"
;[681..684]:quantitative-value:"2.0"
;[685..694]:quantitative-units:"ng/testis"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[473..476] The) (JJ:[477..492] intratesticular) (NN:[493..494] T)
          (NN:[495..502] content))
      (PP (IN:[503..505] of)
        (NP (DT:[506..509] the) (VBN:[510..519] descended)
            (NN:[520..526] testis))))
    (VP (VBD:[527..531] rose)
      (PP
        (PP (IN:[532..536] from)
          (NP
            (NP
              (NP (CD:[537..540] 0.3) (NN:[541..543] ng))
              (PP (SYM:[543..544] /)
                (NP (NN:[544..550] testis))))
            (PP-TMP (IN:[551..553] at)
              (NP
                (NP (CD:[555..557] 14) (NNS:[558..562] days))
                (PP (IN:[563..565] of)
                  (NP (NN:[566..569] age)))))))
        (PP (TO:[570..572] to)
          (NP
            (NP
              (NP (CD:[573..577] 71.2) (NN:[578..580] ng))
              (PP (SYM:[580..581] /)
                (NP (NN:[581..587] testis))))
            (PP-TMP (IN:[588..590] at)
              (NP
                (NP (NN:[591..600] adulthood))
                (PRN (-LRB-:[601..602] -LRB-)
                  (NP (NN:[602..605] day) (CD:[606..608] 56))
                  (-RRB-:[608..609] -RRB-)))))))
      (::[609..610] ;)
      (SBAR-ADV (IN:[611..618] whereas)
        (S
          (PP-LOC (IN:[619..621] in)
            (NP (DT:[622..625] the) (NN:[627..638] cryptorchid)
                (NN:[639..645] testis)))
          (,:[645..646] ,)
          (NP-SBJ (DT:[647..650] the) (NNS:[651..657] values))
          (VP (VBD:[658..662] were)
            (NP-PRD
              (NP
                (NP (CD:[663..666] 0.4) (NN:[667..669] ng))
                (PP (SYM:[669..670] /)
                  (NP (NN:[670..676] testis))))
              (CC:[677..680] and)
              (NP
                (NP (CD:[681..684] 2.0) (NN:[685..687] ng))
                (PP (SYM:[687..688] /)
                  (NP (NN:[688..694] testis))))
              (,:[694..695] ,)
              (ADVP (RB:[697..709] respectively)))
            (,:[709..710] ,)
            (PP (IN:[711..713] at)
              (NP (DT:[714..717] the) (JJ:[718..722] same) (NNS:[723..727] ages)))
            (PRN (-LRB-:[728..729] -LRB-)
              (S
                (NP-SBJ (NN:[729..730] P))
                (ADJP-PRD (JJR:[731..735] less)
                  (PP (IN:[736..740] than)
                    (NP (CD:[741..746] 0.001)))))
              (-RRB-:[746..747] -RRB-))))))
    (.:[747..748] .)))

;sentence 5 Span:749..999
;For determination of the  site of inhibition of T biosynthesis in the
;cryptorchid testis, the enzymatic  activities (17 alpha-hydroxylase,
;17,20-desmolase, and 17 beta-hydroxysteroid  dehydrogenase) in the delta 4T
;biosynthetic pathway were measured.
;[797..798]:substance:"T"
;[866..886]:cyp450:"17 alpha-hydroxylase"
;[888..903]:cyp450:"17,20-desmolase"
;[909..946]:substance:"17 beta-hydroxysteroid  dehydrogenase"
(SENT
  (S
    (PP-PRP (IN:[749..752] For)
      (NP
        (NP (NN:[753..766] determination))
        (PP (IN:[767..769] of)
          (NP
            (NP (DT:[770..773] the) (NN:[775..779] site))
            (PP (IN:[780..782] of)
              (NP
                (NP (NN:[783..793] inhibition))
                (PP (IN:[794..796] of)
                  (NP (NN:[797..798] T) (NN:[799..811] biosynthesis)))))
            (PP-LOC (IN:[812..814] in)
              (NP (DT:[815..818] the) (NN:[819..830] cryptorchid)
                  (NN:[831..837] testis)))))))
    (,:[837..838] ,)
    (NP-SBJ-1
      (NP (DT:[839..842] the) (JJ:[843..852] enzymatic)
          (NNS:[854..864] activities))
      (PRN (-LRB-:[865..866] -LRB-)
        (NP
          (NP (CD:[866..868] 17) (NN:[869..886] alpha-hydroxylase))
          (,:[886..887] ,)
          (NP (NN:[888..903] 17,20-desmolase))
          (,:[903..904] ,) (CC:[905..908] and)
          (NP (CD:[909..911] 17) (NN:[912..931] beta-hydroxysteroid)
              (NN:[933..946] dehydrogenase)))
        (-RRB-:[946..947] -RRB-))
      (PP (IN:[948..950] in)
        (NP (DT:[951..954] the)
          (NML (SYM:[955..960] delta) (NN:[961..963] 4T))
          (JJ:[964..976] biosynthetic) (NN:[977..984] pathway))))
    (VP (VBD:[985..989] were)
      (VP (VBN:[990..998] measured)
        (NP-1 (-NONE-:[998..998] *))))
    (.:[998..999] .)))

;sentence 6 Span:1000..1161
;All these  enzyme activities in the cryptorchid testis were inhibited at 56
;days of age by  about 80% when compared with the descended testis (P less
;than 0.01).
;[1011..1017]:substance:"enzyme"
;[1073..1075]:quantitative-value:"56"
;[1076..1080]:quantitative-units:"days"
;[1098..1101]:quantitative-value:"80%"
(SENT
  (S
    (NP-SBJ-2
      (NP (PDT:[1000..1003] All) (DT:[1004..1009] these)
          (NN:[1011..1017] enzyme) (NNS:[1018..1028] activities))
      (PP-LOC (IN:[1029..1031] in)
        (NP (DT:[1032..1035] the) (NN:[1036..1047] cryptorchid)
            (NN:[1048..1054] testis))))
    (VP (VBD:[1055..1059] were)
      (VP (VBN:[1060..1069] inhibited)
        (NP-2 (-NONE-:[1069..1069] *))
        (PP-TMP (IN:[1070..1072] at)
          (NP
            (NP (CD:[1073..1075] 56) (NNS:[1076..1080] days))
            (PP (IN:[1081..1083] of)
              (NP (NN:[1084..1087] age)))))
        (PP-EXT (IN:[1088..1090] by)
          (NP
            (QP (RB:[1092..1097] about) (CD:[1098..1100] 80))
            (NN:[1100..1101] %)))
        (SBAR-ADV
          (WHADVP-1 (WRB:[1102..1106] when))
          (S
            (NP-SBJ-3 (-NONE-:[1106..1106] *))
            (VP (VBN:[1107..1115] compared)
              (NP-3 (-NONE-:[1115..1115] *))
              (PP-CLR (IN:[1116..1120] with)
                (NP (DT:[1121..1124] the) (VBN:[1125..1134] descended)
                    (NN:[1135..1141] testis)))
              (PRN (-LRB-:[1142..1143] -LRB-)
                (S
                  (NP-SBJ (NN:[1143..1144] P))
                  (ADJP-PRD (JJR:[1145..1149] less)
                    (PP (IN:[1150..1154] than)
                      (NP (CD:[1155..1159] 0.01)))))
                (-RRB-:[1159..1160] -RRB-))
              (ADVP-TMP-1 (-NONE-:[1160..1160] *T*)))))))
    (.:[1160..1161] .)))

;sentence 7 Span:1162..1394
;These data  suggest that cryptorchidism exerts a deleterious effect on the
;ability of the  Leydig cells to synthesize T and may in part explain the
;abnormal morphology and  resultant infertility seen in patients with
;cryptorchidism.
;[1280..1281]:substance:"T"
(SENT
  (S
    (NP-SBJ (DT:[1162..1167] These) (NNS:[1168..1172] data))
    (VP (VBP:[1174..1181] suggest)
      (SBAR (IN:[1182..1186] that)
        (S
          (NP-SBJ (NN:[1187..1201] cryptorchidism))
          (VP
            (VP (VBZ:[1202..1208] exerts)
              (NP (DT:[1209..1210] a) (JJ:[1211..1222] deleterious)
                  (NN:[1223..1229] effect))
              (PP (IN:[1230..1232] on)
                (NP
                  (NP (DT:[1233..1236] the) (NN:[1237..1244] ability)
                    (S-1 (-NONE-:[1244..1244] *ICH*)))
                  (PP (IN:[1245..1247] of)
                    (NP (DT:[1248..1251] the) (NNP:[1253..1259] Leydig)
                        (NNS:[1260..1265] cells)))
                  (S-1
                    (NP-SBJ (-NONE-:[1265..1265] *))
                    (VP (TO:[1266..1268] to)
                      (VP (VB:[1269..1279] synthesize)
                        (NP (NN:[1280..1281] T))))))))
            (CC:[1282..1285] and)
            (VP (MD:[1286..1289] may)
              (PP (IN:[1290..1292] in)
                (NP (NN:[1293..1297] part)))
              (VP (VB:[1298..1305] explain)
                (NP
                  (NP (DT:[1306..1309] the)
                    (NML
                      (NML (JJ:[1310..1318] abnormal)
                           (NN:[1319..1329] morphology))
                      (CC:[1330..1333] and)
                      (NML (JJ:[1335..1344] resultant)
                           (NN:[1345..1356] infertility))))
                  (VP (VBN:[1357..1361] seen)
                    (NP (-NONE-:[1361..1361] *))
                    (PP-LOC (IN:[1362..1364] in)
                      (NP
                        (NP (NNS:[1365..1373] patients))
                        (PP (IN:[1374..1378] with)
                          (NP (NN:[1379..1393] cryptorchidism)))))))))))))
    (.:[1393..1394] .)))

;section 8 Span:1398..1442
;PMID: 2861116 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1398..1402] PMID) (::[1402..1403] :) (CD:[1404..1411] 2861116)
        (NN:[1412..1413] -LSB-) (NNP:[1413..1419] PubMed) (::[1420..1421] -)
        (NN:[1422..1429] indexed) (IN:[1430..1433] for)
        (NNP:[1434..1442] MEDLINE-RSB-)))
